Glaucoma Diagnosis Clinical Trial
Official title:
Sensitivity and Specificity of the NOVA-DN VEP Protocol and a Novel Analysis of Optical Coherence Tomography Images for Glaucoma Diagnosis
| NCT number | NCT02622178 |
| Other study ID # | 11-125E |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | September 2011 |
| Est. completion date | December 2013 |
| Verified date | October 2018 |
| Source | Wills Eye |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Evaluate sensitivity and specificity of NOVA-DN visually evoked potentials (VEP) protocol and new software method (Corda) for glaucoma detection using optical coherence tomography (OCT) images to differentiate between normal subjects and glaucoma suspects.
| Status | Completed |
| Enrollment | 136 |
| Est. completion date | December 2013 |
| Est. primary completion date | December 2013 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: Group 1: Healthy Subjects - intraocular pressure less than 22 millimeters of mercury (mmHg) - normal appearing optic discs and retinal nerve fiber layer (RNFL) - normal optical coherence tomography (OCT) RNFL thickness - normal visual field (VF) results in both eyes. Group 2: Glaucoma Suspects - glaucomatous appearance of optic discs and/or RNFL in at least one eye - normal OCT - normal VF results in both eyes. Group3: Glaucoma Patients - Glaucomatous optic disc appearance (cup to disc ratio, rim thinning or RNFL defects) - Repeatable intraocular pressure (IOP) of 23 mmHg or more, in at least one eye - Repeatable abnormal VF tests Exclusion Criteria: - inability to perform reliable VF or OCT - visual acuity worse than 20/40 - refractive error greater than +/-5.00 diopters sphere, greater than +/- 3.00 diopers cylinder |
| Country | Name | City | State |
|---|---|---|---|
| United States | Wills Eye Hospital | Philadelphia | Pennsylvania |
| Lead Sponsor | Collaborator |
|---|---|
| Wills Eye |
United States,
Waisbourd M, Gensure RH, Aminlari A, Shah SB, Khanna N, Sood N, Molineaux J, Gonzalez A, Myers JS, Katz LJ. Short-duration transient visual evoked potentials and color reflectivity discretization analysis in glaucoma patients and suspects. Int J Ophthalmo — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Visual Evoked Potential (VEP) | Diopsys Visual evoked potential (VEP) (Diopsys, Inc. Pine Brook, NJ) is used to objectively measure the functional responses of the entire visual pathway from the anterior segment of the eye to the visual cortex. This is the strength of the signal recorded from the back of the head near where vision is processed in the brain while a visual stimulus is presented to patient. | 1 examination, one hour | |
| Secondary | Retinal Nerve Fiber Layer Thickness | Optical coherence tomography (OCT) images provide measurement of the retinal nerve fiber layer thickness in microns. | 1 examination, one hour |